IL-33 (also called IL-1F11) is member of the IL-1 family, which induces Th2-type responses, and has been recognized to inhibit the inflammatory response in atherosclerosis by stimulating a Th1-to-Th2 switch and increasing the number of regulatory T cells [9, 23]. This evidence concerns the gene IL1A and atherosclerosis.